$MRNA
SEC EDGAR Filings Hub
2 Filings
$MRNA · Moderna, Inc. SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for Moderna, Inc. ($MRNA) from November 6, 2026 through November 6, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
Check $MRNA portfolio concentration →
View $MRNA Congress trades →
Research $MRNA stock →
All SEC filings →
Total Filings2
10-K / 10-Q Reports1
8-K Material Events1
Form 4 Insider0
High-Impact2
Latest FilingNovember 6, 2026
Browse SEC Filings by Form Type
Latest $MRNA SEC Filings & AI Summaries (2)
November 6, 2026
$MRNA 10-Q — Moderna, Inc.
Moderna's first quarterly profit in years, driven by cost cuts and European sales, marks a potential inflection for a stock that had been mired in losses.
November 6, 2026
$MRNA 8-K — Moderna, Inc.
Moderna's return to profitability plus a doubled revenue-growth outlook signals a durable commercial inflection beyond COVID.
Related & Peer Company SEC Filing Hubs